Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota

Ulcerative colitis (UC) is a nonspecific inflammatory disease. Baicalein has potential value in treating UC, but its mechanism is unclear. This study aims to evaluate the protective effects of baicalein on dextran sodium sulfate (DSS)-induced UC mice. The UC model was established by 4% DSS solution...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiguang Lv, Shengnan Han, Ke Li, Aimin Yan, Wei Wang, Wanping Lu, Jing Han, Chenggang Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1564783/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839608884456587264
author Weiguang Lv
Shengnan Han
Ke Li
Aimin Yan
Wei Wang
Wanping Lu
Jing Han
Chenggang Zhang
author_facet Weiguang Lv
Shengnan Han
Ke Li
Aimin Yan
Wei Wang
Wanping Lu
Jing Han
Chenggang Zhang
author_sort Weiguang Lv
collection DOAJ
description Ulcerative colitis (UC) is a nonspecific inflammatory disease. Baicalein has potential value in treating UC, but its mechanism is unclear. This study aims to evaluate the protective effects of baicalein on dextran sodium sulfate (DSS)-induced UC mice. The UC model was established by 4% DSS solution for 7 days. Treatments included baicalein (10 mg/kg, 20 mg/kg) and sulfasalazine (200 mg/kg) via oral gavage. Colonic damage was assessed through body weight, disease activity index (DAI), histopathology (H&E staining) and colon length. Inflammatory cytokines were measured by ELISA, while oxidative stress markers and iron content were analyzed by colorimetric assays. Protein expression was evaluated by Western blot, and gene levels by RT-qPCR. Intestinal microbiota changes were characterized using 16S rRNA gene sequencing. Results demonstrated that Baicalein ameliorated UC mice, particularly in high-dose of baicalein group. After baicalein treatment, the proinflammatory cytokines (TNF-α, IL-1β), and anti-inflammatory cytokine (IL-10) has decreased. Additionally, high-dose of baicalein strongly reversed oxidative stress alterations caused by DSS, as evidenced by Fe2+, MDA, ROS significantly depleted, and MPO, SOD, GSH significantly increased. Protein and mRNA expression analyses revealed that high-dose baicalein upregulated the expression of FTH1, GPX4, SLC7A11, SLC3A2 and Nrf2, while downregulating ACSL4 significantly. Microbiological analysis showed that baicalein ameliorated intestinal dysbiosis, increased Ligilactobacillus and NK4A136, while reduced Clostridium_sensu_stricto_1 and Escherichia-Shigella. These findings suggest that baicalein mitigates DSS-induced UC mice by reducing oxidative stress and inflammation, suppressing ferroptosis and modulating gut microbiota composition, Proposing a potentially effective therapeutic approach for UC.
format Article
id doaj-art-f7dc60af91bd4d74ba8d5956081fd5ea
institution Matheson Library
issn 1663-9812
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-f7dc60af91bd4d74ba8d5956081fd5ea2025-07-31T05:37:26ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-07-011610.3389/fphar.2025.15647831564783Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiotaWeiguang LvShengnan HanKe LiAimin YanWei WangWanping LuJing HanChenggang ZhangUlcerative colitis (UC) is a nonspecific inflammatory disease. Baicalein has potential value in treating UC, but its mechanism is unclear. This study aims to evaluate the protective effects of baicalein on dextran sodium sulfate (DSS)-induced UC mice. The UC model was established by 4% DSS solution for 7 days. Treatments included baicalein (10 mg/kg, 20 mg/kg) and sulfasalazine (200 mg/kg) via oral gavage. Colonic damage was assessed through body weight, disease activity index (DAI), histopathology (H&E staining) and colon length. Inflammatory cytokines were measured by ELISA, while oxidative stress markers and iron content were analyzed by colorimetric assays. Protein expression was evaluated by Western blot, and gene levels by RT-qPCR. Intestinal microbiota changes were characterized using 16S rRNA gene sequencing. Results demonstrated that Baicalein ameliorated UC mice, particularly in high-dose of baicalein group. After baicalein treatment, the proinflammatory cytokines (TNF-α, IL-1β), and anti-inflammatory cytokine (IL-10) has decreased. Additionally, high-dose of baicalein strongly reversed oxidative stress alterations caused by DSS, as evidenced by Fe2+, MDA, ROS significantly depleted, and MPO, SOD, GSH significantly increased. Protein and mRNA expression analyses revealed that high-dose baicalein upregulated the expression of FTH1, GPX4, SLC7A11, SLC3A2 and Nrf2, while downregulating ACSL4 significantly. Microbiological analysis showed that baicalein ameliorated intestinal dysbiosis, increased Ligilactobacillus and NK4A136, while reduced Clostridium_sensu_stricto_1 and Escherichia-Shigella. These findings suggest that baicalein mitigates DSS-induced UC mice by reducing oxidative stress and inflammation, suppressing ferroptosis and modulating gut microbiota composition, Proposing a potentially effective therapeutic approach for UC.https://www.frontiersin.org/articles/10.3389/fphar.2025.1564783/fullulcerative colitisbaicaleinoxidative stressinflammationferroptosisgut microbiota
spellingShingle Weiguang Lv
Shengnan Han
Ke Li
Aimin Yan
Wei Wang
Wanping Lu
Jing Han
Chenggang Zhang
Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota
Frontiers in Pharmacology
ulcerative colitis
baicalein
oxidative stress
inflammation
ferroptosis
gut microbiota
title Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota
title_full Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota
title_fullStr Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota
title_full_unstemmed Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota
title_short Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota
title_sort baicalein ameliorates dss induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota
topic ulcerative colitis
baicalein
oxidative stress
inflammation
ferroptosis
gut microbiota
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1564783/full
work_keys_str_mv AT weiguanglv baicaleinamelioratesdssinducedulcerativecolitisinmicebyinhibitingferroptosisandregulatinggutmicrobiota
AT shengnanhan baicaleinamelioratesdssinducedulcerativecolitisinmicebyinhibitingferroptosisandregulatinggutmicrobiota
AT keli baicaleinamelioratesdssinducedulcerativecolitisinmicebyinhibitingferroptosisandregulatinggutmicrobiota
AT aiminyan baicaleinamelioratesdssinducedulcerativecolitisinmicebyinhibitingferroptosisandregulatinggutmicrobiota
AT weiwang baicaleinamelioratesdssinducedulcerativecolitisinmicebyinhibitingferroptosisandregulatinggutmicrobiota
AT wanpinglu baicaleinamelioratesdssinducedulcerativecolitisinmicebyinhibitingferroptosisandregulatinggutmicrobiota
AT jinghan baicaleinamelioratesdssinducedulcerativecolitisinmicebyinhibitingferroptosisandregulatinggutmicrobiota
AT chenggangzhang baicaleinamelioratesdssinducedulcerativecolitisinmicebyinhibitingferroptosisandregulatinggutmicrobiota